"Specialized Clinical Trial for study Phase 2, Phase 3 and Phase 4"

During the past decade, Next Innovative Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Next Innovative Clinical Research" are "COVID-19" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Next Innovative Clinical Research" in a lesser frequency.

Most popular intervention types in "Next Innovative Clinical Research" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nipocalimab" (1 trials), "Placebo" (1 trials), "Standard-of-care treatment" (1 trials), "nirmatrelvir" (1 trials) and "placebo for nirmatrelvir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Next Innovative Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Next Innovative Clinical Research". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Next Innovative Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Next Innovative Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".